Topical composition comprising tacrolimus
The present invention relates to a composition for topical application comprising: a first discontinuous phase comprising a first oil and tacrolimus; a second discontinuous phase comprising a second oil; and a continuous aqueous phase; wherein the first oil is different from the second oil.
1. A composition for topical application comprising:
a first discontinuous phase comprising a first oil and tacrolimus, wherein the first oil comprises diisopropyl adipate;
a second discontinuous phase comprising a second oil, wherein the second oil comprises an oil selected from the group consisting of mineral oil, dimethicone, cyclomethicone, hydrogenated polyisobutane, heptamethylnonane, and mixtures of two or more thereof; and
a continuous aqueous phase;
wherein the first oil is different from the second oil,
wherein the tacrolimus is substantially soluble in the first oil and substantially insoluble in the second oil,
wherein said composition has a total surfactant content of less than 1 wt % by weight of the composition, and
wherein the first discontinuous phase and the second discontinuous are separate discontinuous phases so that the first discontinuous phase is dispersed in the continuous phase and the second discontinuous phase is dispersed in the continuous phase.
2. The composition according to claim 1 , comprising less than 5 wt % by weight of the composition of C 1 -C 4 alcohols, polyethylene glycol, ethylene glycol, propylene glycol, butylene glycol, pentylene glycol, glycerol, diethylene glycol mono ethyl ether, propylene carbonate and mixtures thereof.
3. The composition according to claim 1 , wherein the composition has a weight ratio of the second oil to the first oil of from 1:3 to 3:1.
4. The composition according to claim 1 , wherein the composition comprises from 10 to 30 wt % second discontinuous phase by weight of the composition.
5. The composition according to claim 1 , wherein the composition comprises at least 10 wt % water by weight of the composition.
6. The composition according to claim 1 , wherein the composition comprises at most two discontinuous phases.
7. The composition according to claim 1 , wherein the composition has a mean droplet diameter of from 1 to 30 μm.
8. The composition according to claim 1 , wherein the composition has a pH of from 3.5 to 6.
9. The composition according to claim 1 , wherein the composition is stable for at least 12 months at 25° C.±2° C., as measured at 60% RH±5%; and/or wherein the composition is stable for at least 6 months at 40° C.±3° C., as measured at 60% RH±5%.
10. The composition according to claim 1 for use in the treatment of human and/or animal skin by topical application.
11. A method of manufacturing a composition for topical application, the method comprising:
(i) providing a first oil and tacrolimus, wherein the tacrolimus is substantially soluble in the first oil, wherein the first oil comprises diisopropyl adipate;
(ii) providing a second oil, wherein the tacrolimus is substantially insoluble in the second oil, wherein the second oil comprises an oil selected from the group consisting of mineral oil, dimethicone, cyclomethicone, hydrogenated polyisobutane, heptamethylnonane, and mixtures of two or more thereof;
(iii) providing an aqueous component; and
(iv) dispersing the first oil and tacrolimus and the second oil in the aqueous component to form a composition for topical application,
wherein the aqueous component forms a continuous phase in the composition, the first oil and tacrolimus forms a first discontinuous phase in the composition, and the second oil forms a second discontinuous phase in the composition;
wherein the first oil is different from the second oil,
wherein said composition has a total surfactant content of less than 1 wt % by weight of the composition, and
wherein the first discontinuous phase and the second discontinuous phase are separate discontinuous phases so that the first discontinuous phase is dispersed in the continuous phase and the second discontinuous phase is dispersed in the continuous phase.
12. The composition according to claim 1 , having a total surfactant content of less than 0.5 wt % by weight of the composition.
13. The composition according to claim 1 , comprising less than 1 wt % by weight of the composition of C 1 -C 4 alcohols, polyethylene glycol, ethylene glycol, propylene glycol, butylene glycol, pentylene glycol, glycerol, diethylene glycol mono ethyl ether, propylene carbonate and mixtures thereof.
14. The composition according to claim 1 , comprising less than 0.5 wt % by weight of the composition of C 1 -C 4 alcohols, polyethylene glycol, ethylene glycol, propylene glycol, butylene glycol, pentylene glycol, glycerol, diethylene glycol mono ethyl ether, propylene carbonate and mixtures thereof.
15. The composition according to claim 1 , wherein the composition has a weight ratio of the second oil to the first oil of from 2:3 to 3:2.
16. The composition according to claim 1 , wherein the composition has a weight ratio of the second oil to the first oil of about 1:1.
17. The composition according to claim 1 , wherein the composition comprises from 15 to 25 wt % second discontinuous phase by weight of the composition.
18. The composition according to claim 1 , wherein the composition comprises at least 50 wt % water by weight of the composition.
19. The composition according to claim 1 , wherein the composition has a mean droplet diameter of from 1 to 20 μm.
20. The composition according to claim 1 , wherein the composition has a pH of from 4 to 5.5.
21. The composition according to claim 1 , wherein the composition has a pH of from 4.5 to 5.